You are here

HHS to Review Funding for Fetal Tissue Research

Anti-abortionist and Republican Opposition Leads to Cancelation of Contract with Fetal Tissue Firm

The Department of Health and Human Services (HHS) recently canceled a $15,900 contract with fetal research company Advanced Bioscience Resources (ABR) over concerns that the contract failed to include “the appropriate protections applicable to fetal tissue research or met all other procurement requirements.”

In addition, HHS plans to audit all of its contracts with fetal tissue research firms to ensure consistency with statutes and regulations governing such research as well as ensuring that research procedures and oversight are adequate “in light of the serious regulatory, moral, and ethical considerations involved.”

HHS also wants to further investigate alternatives to fetal tissue research. The move is seen as placating antiabortion groups. Eighty-five members of the House of Representatives sent a letter on September 17 to FDA Commissioner Scott Gottlieb, MD, in which they stated their concerns about ABR. Under testimony to Congress, ABR admitted that it had obtained tissue through the collection of human fetal remains from abortion clinics. The lawmakers urged Gottlieb to cancel the contract immediately and use alternative scientific techniques that "do not contribute to the trafficking in human body parts.”

However, scientists who work with fetal tissue point to the advances their research has made for medicine.

Thomas Baldwin, president of the Federation of American Societies for Experimental Biology, wrote in a 2017 letter to Congress that fetal tissue is critical to furthering an understanding of how human tissues develop and are affected by disease. He stated that advances such as the development of vaccines against polio, rubella, measles, chickenpox, and others, and treatments for debilitating diseases depended on research using fetal tissue.

Sources: NBC News, September 25, 2018; Rep. Chris Smith, September 17, 2018; The Hill, September 24, 2018




More Headlines

National Statistics Report Factors In Race, Ethnicity for the First Time
FDA Prioritizing Review of ARB Applications to Help Mitigate Drug Shortage
California Woman Claimed Asbestos in Talc-Based Powder Caused Her Mesothelioma
Synergistic Effects Seen When Combined With Cisplatin in Mice
For Locally Advanced or Metastatic Triple-Negative Type Only
41,000+ Medical Device Reports of Deaths, Serious Injuries, and Malfunctions in 7 Years
Purportedly Sterile Products Made in Unsanitary Conditions, Judge Says
Small-Molecule Drug Blocks Oxidative Stress Signals
MP-101 Has Potential to Drastically Alter Disease Progression